(Q41125577)

English

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes

scientific article published on March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

author name string

Rice CD

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Baldwin NG

2

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Biron RT

3

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Bear HD

4

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Merchant RE

5

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

29-38

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

https://scigraph.springernature.com/pub.10.1023/a:1005771717409

0 references

Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic tumor-specific cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of human gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor-infiltrating lymphocyte (TIL) cytotoxicity facilitated by anti-T-cell receptor antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of cellular immune responses against a glioma-associated antigen(s).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive cellular therapy of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation and in vitro expansion of tumor-reactive T Lymphocytes from lymph nodes draining human primary breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

gamma-Interferon plays a key role in T-cell-induced tumor regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of cytotoxic immune responses during the progression of a rat glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of anti-CD3 monoclonal antibody in the generation of effector cells from human solid tumors for use in cancer biotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-Fold Expansion of Human Cytotoxic T-Lymphocytes Specific for Autologous Melanoma Cells for Use in Immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagents

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9049860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1005771717409

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41125577&oldid=2094100335"